Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease | Zendy

Rachel Boal | Zendy; Yi Shiau Ng | Zendy; Sarah J. Pickett | Zendy; Andrew M. Schaefer | Zendy; Catherine Feeney | Zendy; Alexandra Bright | Zendy; Robert W. Taylor | Zendy; Douglass M. Turnbull | Zendy; Gráinne S. Gorman | Zendy; Tim Cheetham | Zendy; Robert McFarland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease

Author(s) -

Rachel Boal,

Yi Shiau Ng,

Sarah J. Pickett,

Andrew M. Schaefer,

Catherine Feeney,

Alexandra Bright,

Robert W. Taylor,

Douglass M. Turnbull,

Gráinne S. Gorman,

Tim Cheetham,

Robert McFarland

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-00957

Subject(s) - medicine , cohort , mitochondrial disease , disease , body mass index , subclinical infection , overweight , cohort study , mitochondrial dna , gastroenterology , biology , genetics , gene

Abnormal growth and short stature are observed in patients with mitochondrial disease, but it is unclear whether there is a relationship between final adult height and disease severity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research